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Patients with congestive heart failure have been consid-
ered to have augmented sympathetic drive both at rest
and during dynamic exercise. The augmentation ob-
served during exercise may be related to the state of near
exhaustion experienced by patients with heart failure at
relatively low work loads. To compare the response of
the sympathetic nervous system to exercise in normal
subjects and patients with heart failure when they are
working in a comparable physiologicframe of reference,
the data for both groups can be expressed as percent
peak oxygen consumption achieved (percent peak V02)
rather than as a function of absolute oxygenconsumption
(V02) .
Ten healthy control subjects and 31 patients with
chronic clinical class II and III heart failure were studied
during upright maximal bicycleexercise. Eighteen of the
31 patients had primary cardiomyopathy and 13 had
ischemic cardiomyopathy. The average ejection fraction
at rest was 24 ± 10% (±SD) in the group with heart
failure. Heart rate, systolic blood pressure, V02 and
plasma norepinephrine levels were measured at rest and
Patients with chronic congestive heart failure have an altered
responsiveness of the sympathetic nervous system to certain
forms of stress. For example, during orthostasis such pa-
tients have a reduced heart rate response (1,2) and a less
than normal increase in plasma norepinephrine and plasma
renin activity (3,4). The usual decrease in forearm blood
flow in response to upright tilt is also attenuated in heart
failure (5,6), and patients with severe heart failure do not
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throughout exercise. When the data were expressed as
a function of percent peak V02 achieved, patients with
heart failure demonstrated a flatter slope (p = 0.004)
than normal in the response of plasma norepinephrine
to exercise, indicating a relative blunting of sympathetic
drive. This was accompanied by attenuated heart rate
(p = 0.001) and blood pressure (p < 0.001) responses.
These differences were not apparent when the data are
expressed as a function of absolute V02•
Thus, patients with heart failure may have a relative
attenuation rather than augmentation ofsympatheticdrive
during exercise when comparisons are made using a
comparable physiologic frame of reference. Reduced
sympathetic drive might partially explain the blunted
heart rate and blood pressure responses to exercise and
is consistent with the broader hypothesis that heart fail-
ure is characterized by a generalized inability of various
stimuli to maximally activate the sympathetic nervous
system despite increased sympathetic drive in the basal
state.
(J Am Coil CardioI1985;5:832-9)
exhibit an increase in plasma norepinephrine in response to
nitroprusside-induced vasodilation (7).
In addition to abnormal responses to baroreceptor acti-
vation initiated by tilt or pharmacologic vasodilation, pa-
tients with heart failure have an abnormal sympathetic re-
sponse to upright dynamic exercise (8). This abnormality
is characterized by a reduced chronotropic response to ex-
ercise (8), a decrease in stroke volume despite excessive
increments in end-diastolic pressure (9), alterations in the
redistribution of regional blood flow (10) and a reduction
in maximal oxygen consumption (\'02) (II). Early work
by Chidsey et al. (12) suggested that patients with heart
failure demonstrated an augmented sympathetic response to
exercise, as measured by plasma catecholamines, when
compared with a normal control group. This relative aug-
mentation of sympathetic drive occurred despite a reduced
heart rate-blood pressure response, suggesting a lack of
responsiveness of the failing myocardium to catecholamine
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stimulation. In that study neither the patients with heart
failure nor the control patients were exercised maximally.
Using maximal exercise, as defined by a failure of oxygen
consumption to increase further during continued exercise,
we have also noted that patients with heart failure have a
relative augmentation of sympathetic drive early during sub-
maximal exercise when compared with normal control sub-
jects. They do not achieve the extremely high levels of
plasma norepinephrine achieved by normal subjects at max-
imal exercise , perhaps because they do not exercise as long
(13). In the previous report from our laboratory (13) , data
were represented as a function of absolute work intensity
as measured by total body oxygen uptake rather than as a
function of relative work intensity. However, comparing
the plasma norepinephrine in study patients with that of
normal subjects when they are exercising at the same ab-
solute VOz is somewhat misleading because all subjects
(patients and controls) are at varying levels of work inten-
sity. It is therefore possible that the observed " augmented"
sympathetic response to exercise in heart failure compared
with normal subjects is an artifact related to the fact that
patients with heart failure are very near their maximal ex-
ercise tolerance while exercising at a low level of absolute
oxygen consumption. Patients with heart failure and normal
subjects are examined in an uncomparable physiologic frame
of reference . If the oxygen consumption data are expressed
as percent of peak VOz achieved rather than as absolute
VOz, the comparison between patients with heart failure
and normal subjects may be more relative .
In this study we report on an expanded series and rep-
resent the cardiovascular responses to exercise in two ways:
I) as a function of absolute work intensity measured as total
body oxygen uptake, and 2) as a function of relative work
intensity, expressed as percent individual maximal or peak
oxygen uptake. The latter analysis allows a comparison of
patients with congestive heart failure with normal subjects
when all individuals are working at comparable intensities
of exercise, and highlights the importance of making such
comparisons at relative work intensities .
Methods
Patients. Thirty-one male outpatients 32 to 71 years of
age (mean 56) with chronic. stable New York Heart As-
sociation clinical class II to III heart failure were selected
for study. The range of cardiac disease included idiopathic
or alcoholic cardiomyopathy in 18 patients and coronary
artery disease in 13 patients. The presence of coronary dis-
ease was established by coronary arteriography or a previous
history of documented myocardial infarction, No patient had
sustained a myocardial infarction in the 4 months preceding
the study. Two patients had heart failure after aortic or mitral
valve replacement, respectively, at least 5 years before en-
tering the study. All patients had been in clinically stable
condition for at least 4 months before exercise evaluation.
One patient had chronic atrial fibrillation, one had a chronic
junctional rhythm; all others had sinus rhythm. All but one
patient had a standard chest X-ray film obtained before
exercise. and the average cardiothoracic ratio for the group
was 0 .55 :±: 0.06 (:±: SO). Each patient had a radionuclide
left ventriculogram performed at rest before exercise, and
the average ejection fraction was 24 :±: 10%. Twenty-four
of the 31 patients had a technically satisfactory M-mode
echocardiogram before exercise to assess left ventricular
internal diastolic dimension. and the average value for the
group was 69 :±: 10 mm.
Patients were excluded who had exercise-induced angina
pectoris , calf claudication or exercise-induced arrhythmias.
Those with intrinsic pulmonary disease that might limit ex-
ercise were excluded by history. physical examination and
routine spirometry. All patients except two were receiving
long-term digoxin therapy at the time of exercise testing .
and all but five were receiving long-term diuretic therapy.
None was receiving vasodilator therapy at the time of the
study .
A control group was composed of10 healthy men without
cardiovascular disease or major medical illness (mean age
38 years , range 15 to 54). The normal subjects did not
routinely engage in a regular exercise program. All patients
and subjects gave written informed consent which was ap-
proved by the Institutional Review Board of the hospital.
Method of exercise testing. A calibrated electronic bi-
cycle ergometer (Collins) was used for the exercise studies.
The exercise program consisted of a starting work load of
25 watts for patients with heart failure and 50 watts for
normal subjects. The work load was increased every 4 min-
utes by 25 watts until symptomatic maximum. All patients
stopped because of dyspnea or fatigue, and no one was
limited by chest pain, calf claudication, arrhythmia or
electrocardiographic changes. Heart rate and rhythm were
monitored continuously from the electrocardiogram, and
blood pressure was measured by standard cuff technique at
rest and during the second minute of each 4 minute work
load . Heart rate and blood pressure were also measured at
symptomatic maximum. All patients were studied while
sitting upright at least 2 hours after a light meal in an air-
conditioned laboratory.
Metabolic measurements of the expired fractions of OZ,
COzand the minute volume were obtained at rest and during
each work load. Expired air was collected through a Hans
Rudolph nonrebreathing valve into a mixing chamber and
sampled continuously on line by fast responding oxygen and
carbon dioxide gas analyzers (Beckman Metabolic Mea-
surement Cart). Calibration of the gas analyzers with known
precise gas concentrations and calibration of the volume
transducer with a precisely calibrated I liter volume pump
were performed just before and after exercise. Peak oxygen
consumption (peak VOz) was taken to represent the value
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during maximal exhaustion, just before stopping . This value
usually corresponded to the value at which continued ex-
ercise failed to bring about a further increase in \'02, The
percent peak \'02 was calculated retrospectively by dividing
the absolute \'02 at any point in time by the peak \'02
achieved and multiplying by 100.
Plasma norepinephrine. Each patient and normal sub-
ject had a small catheter secured in an antecubital vein the
morning of the exercise test for purposes of drawing blood.
The catheter was placed in the arm opposite to where blood
pressure measurements were made. Blood was drawn after
a period of at least 15 minutes of upright sitting on the
bicycle during the control basal state, and during the third
minute of each exercise work load and during symptomatic
maximum just before stopping the test. In 6 of the 3 I pa-
tients, a sample could not be obtained because of technical
difficulties at some time during the exercise test. Neverthe-
less , each patient and normal subject had at least three data
points, which allowed us to characterize their individual
curves during exercise. The blood samples were immedi-
ately spun in a refrigerated centrifuge and analyzed later
using a radioenzymatic assay (CAT-A-KIT, Upjohn Diag-
nostics). Duplicate measurements of plasma norepinephrine
by this method in our laboratory have a coefficient of vari-
ation of less than 4%.
Statistical analysis. The intent of the analysis was to
quantitatively describe the difference between the group
with heart failure and the control group with respect to
changes in heart rate, systolic blood pressure and plasma
norepinephrine during upright dynamic exercise . Because
of the unusual heterogeneity of the data in the heart failure
group , the patients were further classified into those with
only modest exercise intolerance (able to achieve a work
load of at least 100 watts) and those with severe exercise
intolerance (able to achieve a work load of 50 or 75 watts) .
This distinction, although arbitrary, corresponds roughly
with New York Heart Association clinical classes II and III.
A total of three groups were analyzed as follows: group
I = normal control subjects (n = 10); group 2 = patients
with heart failure able to exercise to a work load of at least
100 watts (n = II); and group 3 = patients with heart
failure able to exercise to only 50 or 75 watts (n = 20).
Because of the complexity of relating multiple variables
in two groups over time, several two and three variable
models were fitted to the log of each individual's data points.
Heart rate, systolic blood pressure and plasma norepineph-
rine were used as the dependent variables, and absolute \'02
and percent peak \'02 achieved were used as the indepen-
dent variables . For each subject the relation between \102
or percent peak \102 and each of the three variables (heart
rate, systolic blood pressure and plasma norepinephrine)
was summarized by two regression coefficients. Multivar-
iate analysis (MANOYA, SPSS version 8.3, Health Science
Computer System, University of Minnesota, with Hotell-
ing's t test as criterion) of the pair of coefficients was per-
formed, which allowed comparison of the three groups . The
group response was estimated by the averages of the coef-
ficients. Subsequent analysis of variance (ANOYA) and t
tests of each of the coefficients were performed to indicate
how the groups differed , if at all. The multiplicity of com-
parisons was taken into account by means of Bonferroni 's
inequality method , and the conclusions were not affected
for a significance level of 0 .05.
Results
Hemodynamic response to exercise. When heart rate
response to exercise is plotted in relation to absolute \'02
(Fig. I), patients with heart failure demonstrate a signifi-
cantly greater (p = 0.01) heart rate response for any given
comparable oxygen consumption . That is, for any given
V02, patients with either mild or severe heart failure have
a higher than normal heart rate. There is no difference in
heart rate response between the groups with mild and severe
heart failure . However, when the oxygen consumption data
are expressed as percent peak \'02 so that all groups are at
equivalent intensities of exercise , this relation reverses and
is consistent with the well known concept that patients with
heart disease display a form of chronotropic incompetence
(Fig. 2). There is a significant (p = 0.(01) difference be-
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Figure 1. The heart rate response to dynamic up-
right exercise is plotted as a function of absolute
work intensity, expressed by total body oxygen con-
sumption (\'02) , The two groups of patients with
heart failure (mild [group 2] and severe [group 3])
are compared with a normal control group of sub-
jects and show a greater (p = 0.01) incremental
increase in heart rate during exercise compared with
normal subjects (group I). Group I versus group 2
(slope), p = 0.01; group I versus group 3 (slope),
p = 0.01 ; group 2 versus group 3 (slope), p =
NS.
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Figure 3. The systolicblood pressureresponseto dynamicupright
exercise is plotted as a function of absolute work intensity, ex-
pressed by total body oxygen consumption (V02) . Although pa-
tients with mild (group 2) and more severe (group 3) heart failure
achieve a much lower V02 than do normal control subjects (group
I) during exercise, the slopes of the curves are not different,
indicating that there is no difference in the incremental change in
systolic blood pressure between groups during upright bicycle ex-
ercise when the response is represented as a function of absolute
work intensity.
Figure 5. The plasmanorepinephrineresponseto dynamic upright
exercise is plotted as a function of absolute work intensity, ex-
pressed by total body oxygen consumption (V02) . AIl slopes are
significantly different (p = 0.004), indicating a higher plasma
norepinephrine leve! during exercise in patients with more severe
heart failure when the response is represented as a function of
absolute work intensity.
ercise (p < 0.001) (Fig. 4). Those patients with more severe
heart failure have a smaller increase in blood pressure during
exercise (p = 0.03).
Plasma norepinephrine response to exercise. The re-
sponse of plasma norepinephrine to dynamic upright exer-
cise is shown in Figures 5 and 6. At any given absolute
V02 , patients with heart failure have a greater level of
plasma norepinephrine. As with heart rate and blood pres-
sure data, however, it may be inappropriate to consider all
three groups to be at equivalent levels of intensity of exercise
even though they are at equivalent absolute values for V02 ,
Figure 4. The systolicbloodpressure responseto dynamic upright
exercise is plotted as a function of relative work intensity, ex-
pressedas percentof individualpeakoxygen uptake(% peakV02) .
AIl slopes are significantly different, indicating that at relative
work intensities, there is less increase in systolic blood pressure
during exercise in those patients with more severe heart failure.
Group 1 versus group 2 (slope), p < O.OO!; group 1 versus group
3 (slope), p < 0.001; group 2 versus group 3 (slope), p = 0.03.
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Figure 2. The heart rate response to dynamic upright exercise is
plottedas a functionof relativeworkintensity,expressedas percent
of individual peak oxygen uptake (% peak V02) . The statisticaIly
significant differencein slopesbetweenthe congestiveheart failure
groups (groups 2 and 3) and the normal group (group I) indicate
that patients with heart failure are unable to raise their heart rate
in response to upright dynamic exercise to the same extent as
normal control subjects when functioning at relative work inten-
sities. Group I versus group 2 (slope), p = 0.001; group 1 versus
group 3 (slope), p < O.00I; group 2 versus group 3 (slope), P =
NS.
tween patients with heart failure and normal control sub-
jects, indicating that those with heart failure have a smaller
incremental increase in heart rate in response to dynamic
upright exercise.
In Figure 3 the systolic blood pressure response to ex-
ercise is plotted in relation to absolute individual V02 . For
any given individual V02 , there is no significant difference
between the three groups with regard to systolic blood pres-
sure during exercise. However, when the three groups are
compared at equivalent levels of exercise (that is, percent
peak V02 achieved), there is a clear and significant sepa-
ration between the groups, with the patients having heart
failure showing a reduced blood pressure response to ex-
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with a more gradual increase at relative work intensities. In
contrast, normal subjects have a somewhat flatter response
during submaximal exercise but show an impressive ex-
ponential rise in plasma norepinephrine when they reach
roughly 50% of their peak V02 and are able to generate a
much higher plasma norepinephrine at peak V02 compared
with patients with heart failure.
The maximal responses of heart rate and systolic blood
pressure to dynamic upright bicycle exercise are shown in
Figure 7. The data indicate that maximal achievable heart
rate and systolic blood pressure responses are blunted as the
severity of heart failure increases. Figure 8 indicates that
the peak V02 achieved varies, as expected, among the three
groups. Although maximal plasma norepinephrine achieved
at peak V02 is greater in normal subjects than in patients
with heart failure, the measurement fails to separate mild
from severe heart failure (Fig. 8).
Figure 6. The plasmanorepinephrine response to dynamic upright
exercise is plotted as a function of relative work intensity, ex-
pressed by percent peak oxygen uptake (% peak V02) . There is
no difference in slope between group 2 (mild heart failure) and
group3 (severeheartfailure).Group I (normal) has a steeperslope
than that in groups 2 and 3 (p = 0.(02), indicating that at relative
workintensities, normal subjects haveaugmented sympathetic drive.
since patients with severe heart failure (group 3) are at near
maximum at a V02 of 10 mllkg per min, while patients
with milder heart failure (group 2) are near maximum at a
V02 of 17 mllkg per min and normal control subjects (group
l) are only at about 50% of peak V02 when exercising at
a V02 of 17 mllkg per min. To circumvent this problem,
the data are again expressed as percent peak V02 achieved
(Fig. 6), which indicates distinctly different shaped curves
for the patients with heart failure and the normal control
subjects (p == 0.(02). Patients with mild or more severe
forms of heart failure begin with higher rest levels of plasma
norepinephrine and respond to upright dynamic exercise
Discussion
The study of various hemodynamic and metabolic re-
sponses to exercise in patients with heart failure is important
because exercise limitation is what ultimately disables the
patient. The mechanisms responsible for limiting the aerobic
exercise capacity of patients with heart failure are unknown
but are possibly related to inadequate blood flow to working
skeletal muscle (14,15) or increased pulmonary capillary
pressure (16). A better understanding of the biologic events
that occur during exercise is needed because it has become
increasingly clear that simple measurements of left ventric-
ular performance at rest do not usually relate to functional
capacity in patients with heart failure (17-20). The func-
tional classification of such patients is best assessed by ex-
ercise testing (21). New pharmacologic therapy for heart
failure is commonly assessed by measuring exercise toler-
ance (22-26). Knowledge of the sympathetic nervous sys-
tem response during exercise may allow for a clearer un-
derstanding of its potential role in either enhancing or possibly
inhibiting exercise tolerance.
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Figure 8. The individual peak \102 obtained
during dynamic upright exercise is different
(p < 0.01) amongall threegroups.The peak
plasma norepinephrine achieved during ex-
ercise is different between the normal and
the two heart failure groups (p < 0.04), but
not between the groups with mild and severe
heart failure ,
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Response of plasma norepinephrine to exercise in heart
failure. Current data indicate that patients with heart failure
have an attenuated sympathetic nervous system response to
stimuli such as orthostasis (3) and acute vasodilation with
nitroprusside (7) . It is therefore somewhat surprising that
the response of the sympathetic nervous system to submax-
imal exercise has been reported to be relatively augmented
rather than attenuated (12,13) . Such augmentation of sym-
pathetic nervous system activity during submaximal exercise
would seem to play a useful role by increasing heart rate
and myocardial contractility. However, the heart rate, blood
pressure and stroke volume responses to exercise are usually
reduced in heart failure. In fact, patients with heart failure
are unable to achieve very high circulating levels of nor-
epinephrine during maximal exercise (13). Blood levels of
at least 1,500 to 2,000 pg/ml (or nearly 10 times the basal
level) of norepinephrine are necessary to achieve a mea-
surable hemodynamic effect when norepinephrine is infused
by vein (27) . Patients with heart failure typically achieve
maximal plasma norepinephrine levels just above this threshold
(Fig. 8) and, in some individual cases, below it during
dynamic exercise .
Comparison of control subjects and patients in similar
physiologic context. The present study has attempted to
examine the sympathetic nervous system response to ex-
ercise over the full spectrum of exercise from rest to ex-
haustion . The response of the plasma norepinephrine rela-
tive to absolute oxygen consumption, as in previous reports
(12,13), has been reexamined and confirms the apparent
augmentation of the sympathetic nervous system response
to submaximal exercise in patients with heart failure (Fig.
5). Although patients with heart failure, when compared
with healthy control subjects, do have a greater plasma
norepinephrine at any given absolute oxygen consumption
during submaximal exercise, it is clear that they cannot do
as much exercise and are therefore closer to peak \'02 or
maximal tolerable exercise at a relatively low oxygen con-
sumption. To analyze the data in a comparable physiologic
frame of reference, the response of plasma norepinephrine
has been plotted as a function of percent peak \'02 achieved
rather than absolute \'02 (Fig. 6) (28). Examination of the
relation between plasma norepinephrine and percent peak
\'02 achieved indicates that the two groups with heart failure
(moderate and advanced) have similar slopes which are less
steep over the duration of exercise compared with those of
normal control subjects. Therefore, in patients with heart
failure plasma norepinephrine can be augmented during ex-
ercise , but the augmentation is somewhat attenuated com-
pared with that in normal subjects at similar work intensities.
This interpretation is opposite to the report of Chidsey et
al. (12) and is also contrary to our own previously published
work (13).
Possible importance of reduced sympathetic drive
during exercise in heart failure. The potential biologic
importance of the relatively attenuated sympathetic nervous
system response to exercise in patients with heart failure
deserves comment. The factors that limit exercise tolerance
in patients are not entirely clear, but may be dependent to
some extent on the ability to increase cardiac output (15),
dilate the peripheral vasculature in response to metabolic
demands (29) and tolerate high left ventricular filling pres-
sures (20). The changes in heart rate, stroke volume and
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arteriovenous oxygen differences are the most important
predictors of maximal oxygen consumption (30). Patients
who are most severely limited by heart failure can increase
cardiac output only by increasing heart rate because they
are unable to improve stroke volume with exertion (14) .
Very high filling pressures may be well tolerated during
exercise (20), and it is likely that the ability to increase
cardiac output and specifically to increase heart rate is of
major importance in determining exercise tolerance in the
syndrome of heart failure . Left ventricular function at rest
is only a weak determinant of exercise capacity (31).
Heart rate response is clearly attenuated during exercise
in patients with heart failure when plotted as function of
relative work intensity (Fig. 2). It is possible, although not
proved, that the attenuated sympathetic nervous system re-
sponse is partly responsible for the blunted heart rate re-
sponse . The inability to maximize the sympathetic response
during exercise and at peak \.'02 could account for the rel-
ative chronotropic incompetence observed in these patients.
Similarly , the blunted systolic blood pressure response to
exercise might also be related to an attenuated sympathetic
response which could contribute to a reduced stroke volume.
It is therefore possible that an attenuated increase in sym-
pathetic nervous system activity during exercise is in part
responsible for the exercise intolerance of heart failure . This
attenuated sympathetic drive during exercise in patients with
heart failure coupled with reduced density of beta-adrenergic
receptors in the failing myocardium (32) may act together
to reduce the chronotropic and inotropic response to exer-
cise, leading eventually to exercise intolerance. This hy-
pothesis is consistent with experimental data demonstrating
a decreased myocardial responsiveness to isoproterenol (33)
and a reduction of the cardiac response to postganglionic
sympathetic nerve stimulation (34) in dogs with heart failure.
Implications. The mechanism of the relatively atten-
uated sympathetic response to exercise in heart failure is
unknown. However, the attenuation is qualitatively similar
to that observed after orthostasis and nitroprusside infusion
in patients with heart failure , although different mechanisms
may be involved. It is possible in some cases to restore
sympathetic responsiveness with pharmacologic therapy (35)
and with more definitive therapy such as heart transplan-
tation (36) . Sympathetic responsiveness to nitroprusside in-
fusion, as with orthostasis and exercise , appears to range
from a near normal response in patients with mild heart
failure to a virtual absence of responsiveness in patients
with severe heart failure (7). Patients who respond to ni-
troprusside with near normal activation of the sympathetic
nervous system appear to have a more favorable long-term
prognosis (7). It is therefore likely that the attenuated re-
sponses of plasma norepinephrine to orthostasis, nitroprus-
side and exercise reflect to some extent the overall severity
of congestive heart failure. In the case of exercise, the
blunted sympathetic response may possibly be contributing
in the exercise intolerance .
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